D-0611-2017 Class II Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-0611-2017 was initiated by Sun Pharmaceutical Industries, Inc. on Mar 15, 2017 and is designated Class II. Reason for recall: Presence of Particulate Matter The recall status is terminated (terminated Apr 23, 2018). Affected quantity: 83,188 single does vials.

Recall details

Product Type
Drugs
Report Date
Mar 29, 2017
Initiation Date
Mar 15, 2017
Termination Date
Apr 23, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
83,188 single does vials

Product description

Testosterone Cypionate Injection , USP, 200 mg/mL, 1 mL vial , For Intramuscular Use Only, Rx Only, Distributed by Sun Pharma Ind. Inc., NJ 08512, Manufactured by Sun Pharma Ind. Ltd. India, NDC 62756-015-40

Reason for recall

Presence of Particulate Matter

Distribution pattern

Nationwide

Code information

JKR0744A, JKR0745A, JKR0750A, JKR0795A; Exp. 09/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0611-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0611-2017. Report a data issue: hello@regdatalab.com.